Arrowhead Pharmaceuticals (ARWR) Stock Surges 481% — Wall Street Eyes Further Gains

Arrowhead Pharmaceuticals (ARWR) gains 3.9% after Morgan Stanley upgrade. Stock up 481% in 12 months with analysts forecasting more upside ahead.

The post Arrowhead Pharmaceuticals (ARWR) Stock Surges 481% — Wall Street Eyes Further Gains appeared first on Blockonomi.